News - Chugai Pharmaceutical, Neurological

Filter

Popular Filters

Surveyed US psychiatrists would prescribe Roche/Chugai's bitopertin to 28% of their patients with negative symptoms of schizophrenia

30-05-2012

US psychiatrists surveyed by advisory firm Decision Resources indicate that they would prescribe Roche/Chugai's…

bitopertinChugai PharmaceuticalGlobalMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalRoche

Back to top